CD274 and non-small cell lung carcinoma: In patients with brain metastases secondary to NSCLC, recent findings indicate a discrepancy in extra- and intracranial PD-L1 expression and a heterogeneity in brain metastases in terms of the PD-L1 expression itself [13, 15, 29].